Bautista TG, Xing T, Fong AY, Pilowsky PM. Recurrent laryngeal nerve activity exhibits a 5-HT-mediated long-term facilitation and enhanced response to hypoxia following acute intermittent hypoxia in rat. J Appl Physiol 112: 1144 -1156, 2012. First published January 12, 2012 doi:10.1152/japplphysiol.01356.2011.-A progressive and sustained increase in inspiratory-related motor output ("long-term facilitation") and an augmented ventilatory response to hypoxia occur following acute intermittent hypoxia (AIH). To date, acute plasticity in respiratory motor outputs active in the postinspiratory and expiratory phases has not been studied. The recurrent laryngeal nerve (RLN) innervates laryngeal abductor muscles that widen the glottic aperture during inspiration. Other efferent fibers in the RLN innervate adductor muscles that partially narrow the glottic aperture during postinspiration. The aim of this study was to investigate whether or not AIH elicits a serotonin-mediated long-term facilitation of laryngeal abductor muscles, and if recruitment of adductor muscle activity occurs following AIH. Urethane anesthetized, paralyzed, unilaterally vagotomized, and artificially ventilated adult male Sprague-Dawley rats were subjected to 10 exposures of hypoxia (10% O2 in N2, 45 s, separated by 5 min, n ϭ 7). At 60 min post-AIH, phrenic nerve activity and inspiratory RLN activity were elevated (39 Ϯ 11 and 23 Ϯ 6% above baseline, respectively). These responses were abolished by pretreatment with the serotonin-receptor antagonist, methysergide (n ϭ 4). No increase occurred in time control animals (n ϭ 7). Animals that did not exhibit postinspiratory RLN activity at baseline did not show recruitment of this activity post-AIH (n ϭ 6). A repeat hypoxia 60 min after AIH produced a significantly greater peak response in both phrenic and RLN activity, accompanied by a prolonged recovery time that was also prevented by pretreatment with methysergide. We conclude that AIH induces neural plasticity in laryngeal motoneurons, via serotonin-mediated mechanisms similar to that observed in phrenic motoneurons: the so-called "Q-pathway". We also provide evidence that the augmented responsiveness to repeat hypoxia following AIH also involves a serotonergic mechanism. laryngeal motoneuron; long-term facilitation; methysergide; postinspiratory; 5-hydroxytryptamine; serotonin THE PAIRED INTRINSIC MUSCLES of the larynx manipulate vocal cord length, tension, and position, to regulate glottic aperture and resistance to airflow during breathing, vocalization, and airway protective reflexes (12, 47, 48, 70) . Bilateral sectioning of the recurrent laryngeal nerve (RLN), which provides the motor supply for all of the intrinsic laryngeal muscles, except the cricothyroid muscles, results in breathing difficulty and aphonia. During eupnea, phasic activity of the laryngeal muscles with respiration is essential for coordinated airflow in and out of the lungs. Laryngeal abductor muscles open the vocal cords, permitting airflow during inspiration (16, 46). In contrast, laryngeal adductor muscles partially close the vocal cords during postinspiration to help maintain a positive end-expiratory pressure to prevent lung collapse, as well as maximizing gas exchange between inspired air and the pulmonary circulation (11, 45).
out of the lungs. Laryngeal abductor muscles open the vocal cords, permitting airflow during inspiration (16, 46) . In contrast, laryngeal adductor muscles partially close the vocal cords during postinspiration to help maintain a positive end-expiratory pressure to prevent lung collapse, as well as maximizing gas exchange between inspired air and the pulmonary circulation (11, 45) .
Acute intermittent hypoxia (AIH) (23, 56, 57, 75) , or intermittent electrical stimulation of the carotid sinus nerve (54) , is a commonly used experimental model to study neural plasticity in the cardiorespiratory system. Episodic (but not sustained) bouts of hypoxia elicit a gradual and sustained increase in respiratory motor output, termed "long-term facilitation" (LTF), resulting in enhanced minute ventilation that is independent of changes in peripheral chemoreceptor input (5, 13) . LTF is observed in humans (36) , as well as awake (73) , sleeping, or anesthetized animals in phrenic (5) , hypoglossal (32) , glossopharyngeal (18) , and external intercostal (31) motor output. Augmented amplitude of phasic discharges in respiratory muscles predominates in the ventilatory LTF observed in naturally sleeping, or anesthetized, paralyzed, and artificially ventilated animals (42, 73, 75) . Thus the effect of AIH has been well characterized on the motor output of primary, and accessory, muscles of inspiration. The current working model of LTF is that neural plasticity at the motoneuronal level, involving serotonin receptor-mediated sensitization of glutamatergic inputs downstream to activation of a Gq-Gprotein-coupled receptor ("Q-pathway") (21, 52, 55) , is necessary and sufficient to produce LTF following AIH (8) . However, although isocapnic hypoxia recruits muscles of active expiration, no study has investigated the effect of AIH on respiratory-motor outputs that control laryngeal adductor muscles that are principally active during postinspiration or expiration.
The aims of the present study were to determine whether 1) AIH elicits LTF of RLN activity (RLNA) occurring in the inspiratory and postinspiratory phases; and 2) LTF of RLNA is mediated by the same serotonergic mechanisms thought to underlie phrenic LTF. Whether or not there was a recruitment of postinspiratory RLNA in animals that did not exhibit postinspiratory activity at baseline was also examined. Our laboratory recently reported that, in addition to LTF, AIH is associated with augmented peak responses in phrenic and splanchnic sympathetic nerves to repeat hypoxia (75) . An additional aim of this study was to examine the role of serotonergic mechanisms in this phenomenon. Lastly, we investigated whether AIH is associated with an augmentation of laryngeal adductor activity during stimulation of the superior larygneal nerve (SLN) (70) .
METHODS

Ethical Approval
This study was approved by the Macquarie University Animal Ethics Committee. All experiments were conducted in accordance with the Australian Code of Practice for the Care and Use of Animals, as endorsed by the National Health and Medical Research Council of Australia.
Drugs
All drugs and other reagents were obtained from Sigma-Aldrich (Australia), except where otherwise indicated.
Animal Preparation
The general surgical preparation and experimental approaches used were similar to those used in our laboratory's previous publications (70, 75) .
Adult male Sprague-Dawley rats (n ϭ 18, 410 -620 g; Animal Resource Centre, Canning Vale, WA, Australia) were deeply anesthetized by an intraperitoneal bolus injection of 10% urethane (wt/vol in saline: 1.3 g/kg). Adequate anesthesia was assessed by absence of a withdrawal reflex and/or changes in breathing or measured blood pressure in response to a noxious paw pinch. Additional intravenous doses of urethane (to a total maximal dose of 1.5 g/kg) were given as required to maintain anesthesia during the surgical preparation and experimental procedures. Rectal temperature was maintained at 36 -37°C at all times using a homeothermic blanket (Harvard Apparatus, Holliston, MA). The right femoral artery and vein were cannulated for blood pressure measurement and drug/fluid administration, respectively. Heart rate was derived from peaks in the blood pressure recording. The right common carotid artery or left femoral artery was cannulated for withdrawal of arterial blood for blood-gas sampling (VetStat, IDEXX, Westbrook, ME). The vagus nerve was isolated and cut on the right side. A tracheostomy below the level of the larynx was performed with care so as to preserve the laryngeal nerves running alongside the trachea. The left phrenic nerve, RLN, and SLN were dissected using a dorsolateral approach, for recording and stimulation using standard bipolar silver electrodes, respectively. The cervical vagus nerve was preserved on this side to enable recording of activity in the RLN, which branches from the main vagal trunk in the thorax. The nerve cavity was kept moist with saline-soaked cotton wool, and later with paraffin oil, to prevent dehydration of nerves. Following nerve dissection, rats were mounted on a stereotaxic frame, paralyzed with pancuronium bromide (iv; initial dose 0.8 mg; 0.4 mg/h maintenance; Astra Pharmaceuticals) and mechanically ventilated (Ugo Basile) with room air enriched with 100% O 2. Standard parameters of ventilation were 65-70 strokes/min with a tidal volume of 1 ml/100 g. Care was taken to minimize changes in ventilation parameters, and only small changes were made to maintain blood-gas parameters. Given the entrainment of respiratory discharges to ventilation rate, tidal volume was adjusted in preference to frequency. Where possible, the original ventilation parameters were maintained at data collection points. An infusion of a 50:50 mixture of lactated Ringer solution (4 mM KCl, 3 mM CaCl 2, 28 mM NaC3H5O3, and 100 mM NaCl) and 5% glucose (5 ml·kg Ϫ1 ·h Ϫ1 ) was started before experimental protocols to help maintain normal blood pH and electrolyte concentrations.
Experimental Protocol
Phrenic nerve and RLN discharges were amplified (ϫ20,000), band-pass filtered (0.1-3 kHz), sampled (5 kHz; Power1401plus, CED, Cambridge, UK), recorded, and analyzed using Spike2 version 7 software (CED, Cambridge, UK).
To establish baseline recordings, ventilation parameters (tidal volume and ventilation frequency) were adjusted to achieve a consistent 1:1 phase-locking of phrenic nerve discharges with arterial PCO 2 (PaCO 2 ) at 40 Ϯ 2 Torr. Bolus injections of 5% wt/vol sodium bicarbonate were given if metabolic acidosis (HCO 3 Ϫ Ͻ 20 mM) was apparent. In a subset of animals (n ϭ 5 AIH; n ϭ 4 AIH ϩ methysergide; n ϭ 6 time control), high-frequency SLN stimulation (0.2-ms pulse width, 20 Hz, 5 s) was applied at increasing voltages (0.5-V increments, up to 0.5 V above threshold) to determine the threshold voltage needed to abolish phrenic activity (phrenic apnea) for the duration of stimulation. Nerve and blood pressure recordings were allowed to return to and stabilize at baseline levels for 10 min before animals were subjected to one of three protocols: AIH, AIH ϩ methysergide, or "time control".
AIH. The AIH protocol consisted of 10 exposures to a hypoxic gas mixture (10% O 2 in N2, 45 s per exposure) pumped through the ventilator inlet, each separated by 5 min of ventilation with 100% oxygen-enriched room air. During the hour following AIH, arterial blood gases were sampled at 15, 30, 45, and 60 min posthypoxia and corrected so that they were comparable to baseline values [arterial PO 2 (PaO 2 ): Ͼ300 Torr; PaCO 2 : within 3 Torr of baseline]. Correction of blood-gas variables involved small changes to the ventilation (tidal volume in preference to frequency) to correct Pa CO 2 , or by giving an intravenous bolus dose of 5% sodium bicarbonate to adjust for metabolic acidosis, if necessary. At 60 min post-AIH, repeat hypoxic exposure (10% O 2 in N2, 45 s; at least once) was then performed in all animals. In the subset of animals that were subjected to SLN stimulation, the threshold voltage required to produce phrenic apnea was retested.
AIH ϩ methysergide. The broad spectrum 5-hydroxytryptamine (5-HT) receptor antagonist, methysergide maleate (4 mg/kg) was administered intravenously in this subset of animals to provide irreversible blockade of serotonergic neurotransmission. This dose was selected based on previous AIH studies in rats (e.g., Ref. 5). After methysergide injection, animals were left for 20 min to enable the drug to take effect and to establish stable baseline levels. Blood samples were collected and ventilation adjusted to correct for bloodgas measurements. The threshold voltage of SLN stimulation required to elicit phrenic apnea was tested after methysergide administration but before the start of the AIH protocol, as outlined above. Both the hypoxic chemoreflex (10% O2 in N2, 45 s; at least once) and the threshold voltage of SLN stimulation, required to elicit phrenic apnea, were retested 60 min post-AIH.
Time control. Time control animals were not subjected to the AIH protocol, but instead were left undisturbed for the equivalent amount of time required to run the AIH protocol (i.e., 10 ϫ 45 s ϩ 5 min), to account for any fluctuations in recorded parameters over time. Blood gases were measured and corrected only at 30 and 60 min following this control period, as it was assumed that their condition was more stable.
At the end of all experimental protocols, animals were euthanized with an intravenous injection of 10% KCl.
Data Analysis
To determine whether or not blood-gas values changed over time, a one-way ANOVA across the different time points was used in each experimental group and between groups.
For all analysis purposes, both raw phrenic nerve activity (PNA) and RLNA were rectified and smoothed (time constant ϭ 0.01 s). The respiratory cycle, and corresponding RLNA, was defined by three phases: inspiration (I), postinspiration (P-I), and expiration (E). I was defined as the duration between the start of the phrenic nerve discharge to its peak discharge. Thereafter, P-I was defined as the duration between the peak of the inspiratory phrenic nerve discharge to the end of the decrementing discharge in RLNA (See Fig. 1B ). This is similar to the definition of P-I using whole vagus nerve (29) . E was defined as the duration between the end of P-I and the onset of the following phrenic nerve discharge.
To analyze the RLN response to acute hypoxia, phrenic cycletriggered averaging was used to compare the distribution of RLNA across the different respiratory phases. The baseline pattern of RLNA was determined by averaging the activity for 60 s immediately before the first hypoxic exposure of the AIH protocol. The area under the curve (AUC) of the integrated RLN trace was calculated for each respiratory phase and expressed as a percentage of AUC of the whole respiratory cycle. Activity during the first hypoxic exposure, the posthypoxic frequency decline (PHFD) and recovery periods were determined. The hypoxic period was defined as the start, to the end, of the 10% O 2 in N2 "wash-in" (45 s). The PHFD was defined as the period (Ն10 phrenic cycles) following the hypoxic gas "wash-in", wherein an abrupt change in mean arterial pressure (MAP) was observed, and the frequency of phase-locking of respiratory-related nerve discharges to the artificial ventilation rate noticeably decreased. The recovery period was defined as the 60 s after the PHFD when the phase-locking recovered its baseline 1:1 pattern or otherwise became stable. Two-way ANOVA with repeated measures, followed by post hoc analysis using multiple comparisons and Bonferroni's correction, were used to compare the RLNA across the phases.
To determine whether LTF had occurred, the values of phrenic and RLNA amplitude and MAP were averaged for 50 cycles at each time point [baseline (before AIH); 15, 30, 45, and 60 min after AIH] when the arterial blood-gas measurements were adjusted to levels similar to that during the baseline period. In the AIH ϩ methysergide group, the baseline period was defined as the 20 min after methysergide was injected, but before the first AIH. When analyzing RLNA, peak amplitude in I was analyzed, and the peak in P-I was also analyzed when present. Both the change from baseline and differences between groups in the post-AIH phrenic and RLNA amplitude were statistically analyzed using a two-way ANOVA with repeated measures, followed by post hoc analysis using multiple comparisons and Bonferroni's correction.
To determine whether sensitization of responses to acute hypoxia occurred following AIH, the peak change in amplitude of PNA and RLNA to the first hypoxic exposure and to the repeat hypoxic exposure 60 min post-AIH in the AIH and AIH ϩ methysergide groups were compared. The time taken from the onset of hypoxia until the respiratory discharges in RLNA and PNA returned to baseline frequency (before hypoxia) was also quantified. Paired Student's t-tests were used to compare the values for the first hypoxic exposure with the repeat hypoxic exposure 60 min post-AIH in each group.
In the subset of animals that received SLN stimulation, a two-way ANOVA was used to compare the change in absolute values of threshold voltages for SLN stimulation before and after treatment in the different experimental groups. RLNA during SLN stimulation was quantified by two methods. Peak RLNA amplitude and AUC of the integrated RLNA, during SLN stimulation, before and after treatment, were determined. The change in peak amplitude and AUC following treatment was expressed as a fold difference from the peak amplitude during stimulation in the baseline period. Expression as a fold difference accounted for variations in absolute values of nerve activity. A one-way ANOVA was used to compare the normalized peak RLNA amplitude and AUC during SLN stimulation following treatment across experimental groups.
Statistical analyses were all performed in Graphpad Prism (version 5.0). P Ͻ 0.05 was considered significant. All values are expressed as means Ϯ SE.
RESULTS
Anesthetized, unilaterally vagotomized, paralyzed, and artificially ventilated rats were subjected to one of three treatments: AIH (n ϭ 7), AIH ϩ methysergide (n ϭ 4), or no treatment that served as "time control" (n ϭ 7).
Blood Gases and MAP
Baseline pH, Pa CO 2 , and HCO 3 Ϫ levels were not significantly different across all experimental groups (AIH, AIH ϩ methysergide, and time control) ( Table 1 ). In each experimental group, the mean Pa CO 2 values at 15, 30, 45, and 60 min posttreatment were not different from baseline values or between groups (Table 1) , indicating a consistent isocapnic condition throughout the experiment. Similarly, Pa O 2 remained unchanged in all samples examined before and after AIH, indicating a consistent hyperoxic condition that eliminated fluctuations in O 2 as a variable (46) . MAP before any intervention was similar across all groups. Both AIH and time control maintained similar MAP throughout the experimental protocol. However, MAP was significantly decreased in the AIH ϩ methysergide group after AIH (Table 1) .
Baseline RLNA and PNA
PNA was phase-locked with ventilation, due to the presence of an intact vagus nerve. The majority of animals exhibited a 3 Ϫ , and MAP. *P Ͻ 0.001, compared with the baseline in AIH ϩ methysergide.
1:1 phase-locking of respiratory discharge to ventilation rate (AIH: n ϭ 6/7, AIH ϩ methysergide: n ϭ 2/4, and time control: n ϭ 5/7), but a subset of animals in each group exhibited 1:2 phase-locking (n ϭ 1/7 AIH, n ϭ 2/4 AIH ϩ methysergide, and n ϭ 2/7 time control). Most animals exhibited RLNA activity largely in I, with little or no activity in P-I, before AIH, with the exception of n ϭ 1/7 AIH, n ϭ 3/4 AIH ϩ methysergide, and n ϭ 2/7 time control animals.
RLNA During Acute Hypoxic Exposure
The responses of the PNA and RLNA were determined during the first hypoxic exposure in the AIH group. During hypoxia, the duration of each respiratory phase (I, P-I, and E) was not changed compared with their baseline values (Fig. 1C) . During PHFD, the phase-locking of the phrenic cycle to ventilation often changed from a 1:1 to a 1:2 pattern (Fig. 1B) . In some animals, a few respiratory discharges became completely uncoupled with ventilation before the onset of the 1:2 pattern (data not shown). Thus the total phrenic cycle duration doubled during PHFD (0.84 Ϯ 0.01 s baseline vs. Fig. 1C ). The duration of I during PHFD was not different from baseline. All animals returned to 1:1 phase-locking (with the exception of one animal that remained phase-locked 1:2) before the second hypoxic exposure was performed.
Phrenic cycle-triggered ensemble averages of RLNA showed that the activity was differentially distributed within the phrenic cycle (Fig. 1, B and D) . At baseline, RLNA comprised predominantly inspiratory (61 Ϯ 3%), some postinspiratory (31 Ϯ 3%), and little expiratory activity (8 Ϯ 1%) (Fig. 1D) . Peak RLNA amplitude usually occurred during the inspiratory burst; a small but distinguishable P-I peak of approximately the same amplitude was present in only one animal (Fig. 1B) . In contrast, during hypoxia and the PHFD, the peak amplitude in RLNA shifted to P-I, although there was an overall increase in amplitude in all phases (Fig. 1B) . During hypoxia, the proportion of RLNA activity in I decreased (from 61 Ϯ 3 to 44 Ϯ 3%, P Ͻ 0.05; Fig. 1D ), while the activity in P-I increased (from 31 Ϯ 3 to 48 Ϯ 3%, P Ͻ 0.05; Fig. 1D ). The changes observed were further exaggerated during PHFD (I: from 61 Ϯ 3 to 37 Ϯ 5%, P Ͻ 0.001; P-I: from 31 Ϯ 3 to 53 Ϯ 4%, P Ͻ 0.001; Fig. 1D ). On the other hand, RLNA during E remained unchanged from baseline, during the acute hypoxic exposure, and the PHFD.
The respiratory phase durations and pattern changes in PNA and RLNA during acute hypoxic exposure were similar in the AIH ϩ methysergide group (data not shown). Peak amplitude in RLNA and PNA during acute hypoxic exposure was not different from the AIH group (RLNA: AIH 169 Ϯ 13% vs. AIH ϩ methysergide 169 Ϯ 12%; PNA: AIH 178 Ϯ 12% vs. AIH ϩ methysergide 164 Ϯ 7%).
RLNA and PNA LTF
In the 60 min following AIH when the animals were returned to the hyperoxic condition, the distribution of RLNA across respiratory phases was not different to its distribution before the AIH protocol in all experimental groups ( Fig. 2A,  insets) . In other words, animals that exhibited RLNA in only the I phase at baseline did not maintain the hypoxia-induced peak in P-I phase following AIH, indicating no long-term recruitment of P-I activity in the RLN. Animals that exhibited a P-I peak in RLNA at baseline maintained this peak following AIH.
The amplitude of the inspiratory peak in RLNA exhibited an overall, progressive, and sustained increase following AIH in the AIH group (Fig. 2A) . In contrast, blockade of serotonin receptors by methysergide before AIH abolished this increase in inspiratory RLNA (Fig. 2B) . The time control group exhibited no change in the inspiratory RLNA after the equivalent time. At 60 min post-AIH, the amplitude of the inspiratory peak in RLNA was significantly greater in the AIH group (n ϭ 7; 23 Ϯ 6% of baseline; P Ͻ 0.05; Fig. 3A) , whereas it was unchanged from baseline in the AIH ϩ methysergide (n ϭ 4; Ϫ15 Ϯ 9%; P Ͼ 0.05; Fig. 3A ) and time control (n ϭ 7; Ϫ3 Ϯ 6%; P Ͼ 0.05; Fig. 3A) groups.
There was a group-specific effect of AIH on the postinspiratory peak in the subset of animals that exhibited this activity. In the single animal in the AIH group with a clear P-I peak, the amplitude increased by 21% at 60 min post-AIH. In contrast, in the AIH ϩ methysergide group, the amplitude of the P-I peak decreased (n ϭ 3; Ϫ22 Ϯ 5%). There was no change in the amplitude of the peak in P-I in the time control group (n ϭ 2; Ϫ4 Ϯ 0%). Given the small number of animals with a P-I peak in each treatment group, no statistical analysis was performed.
As with inspiratory RLNA, the peak amplitude of PNA exhibited an overall trend of progressive increase following AIH in the AIH group ( Fig. 2A) , an effect that was abolished by pretreatment with the serotonin receptor antagonist methysergide (AIH ϩ methysergide, Fig. 2B ). There was also no change in PNA amplitude in the time control group after an equivalent recording duration (P Ͻ 0.001, Fig. 3B ). At 60 min post-AIH, peak amplitude in PNA increased by 39 Ϯ 12% in the AIH group (P Ͻ 0.05; Fig. 3B ). In contrast, PNA amplitude remain unchanged from baseline in the AIH ϩ methysergide and time control groups (0 Ϯ 4% and Ϫ6 Ϯ 5%, respectively; P Ͼ 0.05; Fig. 3B ).
Effect of Repeat Hypoxic Exposure Following AIH
At 60 min post-AIH, both the AIH and AIH ϩ methysergide groups were again exposed to a single brief hypoxia (10% O 2 in N 2 for 45 s; Fig. 4, A and B) . The peak amplitudes of RLNA and PNA during this repeat hypoxia were compared with that of the first hypoxic exposure during the AIH protocol. In the AIH group, the peak amplitude of both nerves was significantly enhanced 60 min post-AIH (RLNA: 169 Ϯ 13 vs. 224 Ϯ 10% of prehypoxia baseline, P Ͻ 0.05; PNA: 178 Ϯ 12 vs. 235 Ϯ 21% of prehypoxia baseline, first vs. repeat hypoxia, P Ͻ 0.05; Fig. 4, A, C, and D) . The RLNA pattern and distribution across respiratory phases were not different between the two hypoxic exposures. In comparison, pretreatment with methysergide eliminated the enhanced peak amplitude response of both the RLN and PNA during the repeat hypoxic exposure (RLNA: 169 Ϯ 12 vs. 169 Ϯ 22% of prehypoxia baseline; PNA: 164 Ϯ 7 vs. 165 Ϯ 16% of prehypoxia baseline, first vs. repeat hypoxia, P Ͼ 0.05; Fig. 4 
, B, C, and D).
We also compared the duration of the PHFD between the first hypoxic exposure during the AIH protocol and the repeat hypoxia given 60 min post-AIH (Fig. 4E) . In the AIH group, the time taken for respiratory frequency to return to its prehypoxia value was longer post-AIH compared with the first hypoxia (AIH: 125 Ϯ 23 s first hypoxia vs. 293 Ϯ 36 s repeat hypoxia, P Ͻ 0.01; Fig. 4 A and E) . In animals pretreated with methysergide, there was no difference in the time taken for the frequency to return to prehypoxia rate before or after AIH (AIH ϩ methysergide: 135 Ϯ 34 s first hypoxia vs. 133 Ϯ 33 s repeat hypoxia, P Ͼ 0.05; Fig. 4, A, B , and E).
Responses to SLN Stimulation Before and After AIH
The responses of PNA and RLNA to high-frequency SLN stimulation (pulse width 0.2 ms, 20 Hz for 5 s) was tested in a subset of animals in each treatment group (n ϭ 5 AIH; n ϭ 4 AIH ϩ methysergide; n ϭ 6 time control). In all animals, increasing voltages of SLN stimulation eventually resulted in phrenic apnea, nonrespiratory-related burst activity in the RLN, and a pressor response (Fig. 5A) . The threshold voltage required to produce phrenic apnea at baseline was not different between experimental groups (AIH: 2.1 Ϯ 0.4 V; AIH ϩ methysergide: 1.8 Ϯ 0.1 V; time control: 2.4 Ϯ 0.4 V; P ϭ 0.7; RLNA during SLN stimulation at threshold was also quantified. The AUC of integrated RLNA during SLN stimulation post-AIH was expressed as a ratio of the value during SLN stimulation given at baseline (pre-AIH) (Fig.  5C ). Although this ratio was greater in the AIH group (ratio ϭ 2.2 Ϯ 0.5) compared with the AIH ϩ methysergide (1.2 Ϯ 0.2) and time control groups (1.4 Ϯ 0.2), no statistical difference was found across groups (P ϭ 0.08). Similarly, maximum RLNA amplitude during SLN stimulation was determined (data not shown). The value during SLN stimulation given post-AIH was expressed as a ratio of the value during SLN stimulation given at baseline (pre-AIH). Again, although the AIH group exhibited an enhancement of maximum amplitude post-AIH (ratio ϭ 1.4 Ϯ 0.2) compared with the AIH ϩ methysergide (1.1 Ϯ 0.1) and time control groups (1.1 Ϯ 0.0), no statistical difference was found across groups (P Ͼ 0.1)
DISCUSSION
The principal findings of the current investigation are that AIH elicits LTF of inspiratory laryngeal abductor motor output that likely involves serotonergic-mediated sensitization of laryngeal abductor motoneurons, similar to that described for phrenic LTF. Furthermore, although robust postinspiratory activity in RLN is observed during each hypoxic stimulation in animals, the potentiated postinspiratory activity is not maintained after return to hyperoxic conditions, at the end of the 10 AIH stimulations. Animals that exhibited postinspiratory RLNA at baseline still exhibited this activity post-AIH; correspondingly, animals that lacked postinspiratory RLNA at baseline also lacked this activity post-AIH. This suggests that laryngeal adductor muscles are not recruited during the development of ventilatory LTF. We further demonstrate that, following AIH, the augmented peak amplitude and the prolonged duration of responses to repeat hypoxia observed in PNA and RLNA also involves a serotonergic mechanism. However, the prolonged time domain of hypoxic responses following AIH suggests that additional mechanisms other than the sensitization of motoneurons may be involved. 
Technical Considerations
Our study employed unilaterally vagotomized animals, in contrast to previous studies of neural plasticity following AIH that have either used bilaterally vagotomized or vagal-intact preparations (7, 34) . This preparation was essential, as preservation of at least one vagus nerve was required to record the RLN, which is difficult to isolate caudally from where it branches off the vagus nerve in the thorax. One advantage of this preparation was the ability to entrain respiratory discharges to ventilation, thus allowing amplitude LTF to be studied in isolation without the confounding effects of increased respiratory frequency, which can occur in bilaterally vagotomized preparations (34) , and arises from a separate mechanism within central respiratory rhythm-generating circuits (7) . Removal of some vagal influence was also desirable, as postinspiratory activity of laryngeal adductor muscles during eupnea and hypoxia is largely suppressed in the presence of vagally mediated inhibitory input from lung stretch receptors (10, 24) . The presence of vagal influence additionally bears on the magnitude of upper airway LTF (34, 50) , as it tends to constrain LTF, although LTF can be still observed in vagally intact animals (67, 72) . In sum, unilateral vagotomy conferred several advantages, although we contend that LTF may be partially constrained by the presence of vagal inputs, leading to an underestimation of the extent of LTF in the present study.
A limitation of our study is the use of nerve activity as a surrogate for muscle activity. In our study, whole RLN recording was employed because of the technical difficulties in identifying and recording nerves innervating individual laryngeal muscles in a small animal, such as a rat. The RLN innervates two types of muscles with functionally opposite effects on vocal cord movement and glottic aperture. RLNA during I represents contraction of the primary laryngeal abductor muscle (the posterior cricoarytenoid) to widen the glottic aperture to enable airflow (43) . Paradoxical laryngeal adduction during I is only observed in severe hypoxic gasping in (vagotomized) neonatal rats and during hiccup (25) . In contrast, postinspiratory activity in the RLN most likely represents contraction of laryngeal adductor muscles (thyroarytenoid, lateral cricoarytenoid, and interarytenoid) that act to regulate expiratory airflow by decreasing the glottic aperture. The posterior cricoarytenoid can also exhibit activity during P-I, but this is minimal (10, 43) . Thus the interpretation of which functional laryngeal muscle type was active from whole RLNA recording is relatively straightforward, given the phase-restricted activities of both muscle types.
AIH Elicits LTF of Inspiratory-Modulated Laryngeal Abductor Muscles But Does Not Recruit Additional Expiratory Activity
Laryngeal resistance contributes ϳ30% of upper airway resistance and is an important determinant of airflow to the lungs (47) . We demonstrate that AIH evokes amplitude LTF of inspiratory RLNA, providing evidence for greater laryngeal abduction of the vocal cords and a decrease in subglottic resistance to airflow. Our findings are in agreement with previous demonstrations of LTF in other inspiratory-modulated upper airway muscles and their associated nerves following intermittent hypoxia or peripheral chemoreceptor stimulation, including the genioglossus (5, 32), hyoglossal (67), glossopharyngeal (18) , and nasal dilator (50) muscles. Our data complement the observation that there is a fall in supraglottic resistance to airflow following episodic hypoxia in sleeping humans (1, 64) . Some investigators have reported that LTF of upper airway muscles can occur independent of diaphragm LTF (19, 50) and was suggested as a way to increase tidal volume without increasing the depth of breathing (4). However, in our study, LTF of inspiratory RLNA always occurred in parallel with PNA. Taken together, our work and that of others imply that AIH initiates concerted, neural plasticity within all inspiratory motor outputs to maximize airflow to the lungs and thus oxygen availability.
Studies of LTF elicited by AIH has, to date, focused on inspiratory-modulated respiratory activity and have not investigated respiratory motor outputs active in P-I/E. If hypoxia recruits the normally quiescent muscles of active E, e.g., the external oblique muscles (30, 38, 49) , as well as postinspiratory laryngeal adductor muscles (25) (see later section), it might be expected that AIH would result in the stable, longterm recruitment of such muscles. Furthermore, sympathetic nerve activity in P-I/E is increased following AIH and chronic intermittent hypoxia, due to recruitment of a latent expiratory drive (23, 58, 75, 77) , indicating changes in the neural control during E. Our study is the first to examine the effect of AIH on postinspiratory and expiratory activity in the respiratory system. We present novel data demonstrating that AIH does not recruit "additional" postinspiratory laryngeal adductor muscle activity than what was already present at baseline. This lack of recruitment is not due to the inability of the system to express postinspiratory activity, as laryngeal adductor muscle activity is readily recruited during hypoxia (see later section). In addition, rhythmic laryngeal adduction was observed as bursting activity in RLN in response to SLN stimulation, which represents fictive swallow or laryngospasm elicited by laryngeal irritation (2, 68, 70) . Our data lend further credence to the notion that, at least in AIH, amplitude LTF is due to a sensitization of respiratory motoneurons to existing excitatory input. Amplitude LTF, unlike frequency LTF, is not considered to produce long-lasting changes in respiratory rhythm and pattern generators (7), such as unmasking excitatory drives, e.g., from the "active expiratory rhythm generator" to recruit more expiratory motoneurons than those already active at baseline. This is further supported by our finding that the apneic threshold during SLN stimulation was unchanged by AIH, as SLN-induced apnea requires activation of the Bötzinger complex to arrest respiratory rhythm at E (15, 68, 70) .
On the other hand, it is possible that AIH did sensitize laryngeal adductor motoneurons to excitatory inputs, but this sensitization may be masked by the minimal drive to laryngeal adductor motoneurons in the baseline condition. However, sensitization of laryngeal adductor motoneurons can be observed during reflexes that strongly excite such motoneurons. We noted an enhancement of the peak amplitude of RLNA in response to repeat brief hypoxia (see later section). It is also interesting to note that there was LTF of postinspiratory activity in the single animal in the AIH-only group that exhibited this activity at baseline. High-frequency SLN stimulation, mimicking laryngeal irritation, was also performed, as this produces powerful reflex laryngeal adduction (2, 70) . However, we did not observe an augmented laryngeal adductor activity during this intervention. A likely explanation is that SLN stimulation at the threshold voltage to elicit apnea was used; reliable high-amplitude RLN burst activity can only be produced by SLN stimulation at least 1.3-1.5ϫ threshold voltage (70) . We chose not to perform multiple SLN stimulations, as intermittent vagal stimulation can, in itself, induce respiratory motor LTF (76) .
Mechanism of LTF in RLNA
Our finding that LTF of RLN amplitude is serotonin dependent suggests that AIH induces neural plasticity in laryngeal motoneurons in a manner similar to amplitude LTF in phrenic and other respiratory motoneurons (5, 18) . Amplitude LTF of both RLNA (inspiratory and postinspiratory) and PNA were completely abolished by pretreatment with methysergide, a nonselective 5-HT receptor antagonist. This is consistent with the current model that LTF induction in phrenic nerve requires serotonin release during the acute hypoxic episodes (33) to activate brain-derived neurotrophic factor-tropomyosin-related kinase B receptor signaling mechanisms within phrenic motoneurons (6) . The downstream intracellular signaling cascades are thought to sensitize motoneurons to glutamatergic inputs by enhancing N-methyl-D-aspartate receptor depolarizing currents, as pretreatment with N-methyl-D-aspartate receptor antagonists also eliminates LTF (18, 52) . Neural plasticity at the motoneuronal level is sufficient to produce LTF, since local administration of the agonists, 5-HT or brain-derived neurotrophic factor, or antagonism with selective receptor blockers at the phrenic motoneurons selectively blocked phrenic LTF, while preserving hypoglossal LTF (6, 8) .
The participation of serotonin in the production of LTF at laryngeal motoneurons is consistent with the strong evidence for serotonergic modulation of laryngeal motoneuronal activity. Our laboratory's previous work demonstrated that, like phrenic (65) and hypoglossal (41) motoneurons, both laryngeal abductor and adductor motoneurons are closely apposed by many serotonergic boutons (14, 71) . Laryngeal motoneurons express 5-HT 2A receptor (27, 28) , and the activation of 5-HT 2A receptors results in neuronal depolarization and increased spiking activity (3) . The source of excitatory serotonergic inputs to laryngeal motoneurons originates from the raphe pallidus and obscurus (3, 37) , the latter of which also exhibits increased firing activity following episodic hypoxia and is speculated to provide the serotonergic input required for LTF in respiratory motoneurons (59) . These findings, together with our present data, support the conclusion that similar serotonergic mechanisms are involved in the sensitization of laryngeal motoneurons and the production of amplitude LTF of inspiratory RLNA, as observed in the phrenic motoneurons.
While evidence strongly suggests that LTF occurs at the motoneuronal level, our experimental approach (systemic serotonergic antagonism) does not preclude the possibility of neural plasticity occurring at the level of premotoneurons, as suggested by the work of Morris et al. (59) . The authors proposed that the increased synchronicity of firing in inspiratory-augmenting neurons in the rostral ventral respiratory group (presumably phrenic premotoneurons) following AIH enables the temporal summation of inputs, and, therefore, stronger synaptic drive, to phrenic motoneurons. However, while studies by Morris and colleagues suggest increased premotor firing rates and changed connectivity 15-20 min following intermittent peripheral chemoreceptor activation, it is not clear that these changes persist up to 1 h after the stimulation protocol. It is noteworthy that inspiratory-augmenting neurons in this area also function as laryngeal premotoneurons (26, 60) . This may provide the anatomical substrate for the parallel LTF of RLNA and PNA observed in our study.
Laryngeal Response to Brief Hypoxic Exposure
Under baseline (hyperoxic-eupneic) conditions, our unilaterally vagotomized preparation functioned similar to a vagalintact animal. Respiratory burst discharges were entrained to mechanical ventilation, and postinspiratory RLNA was either not present or minimal in most animals, in agreement with minimal laryngeal adductor activity in vagal-intact animals (9, 10, 24) . During brief hypoxic exposure, inspiratory activity of the RLN progressively increased in amplitude, consistent with the well-documented increase in laryngeal abductor activity and decrease in laryngeal resistance to airflow in hypoxia (9, 10, 17, 51) . The increase in airflow is further facilitated by the suppression and/or silence of the laryngeal adductor muscles in the vagal-intact condition (9, 39, 44, 69, 74) . In contrast, in bilaterally vagotomized animals, or animals lacking functional lung-stretch receptor inputs, there is a powerful recruitment of laryngeal adductor muscles during hypoxia that results in increased laryngeal resistance during P-I (10, 24, 25) . In our preparation, there was an emergence of a sharp, decrementing peak in P-I during hypoxia and the PHFD (Fig. 1, A and B) , signifying recruitment of laryngeal adductor muscle activity. Therefore, it appears our preparation functioned more like a vagotomized animal during hypoxia. It is important to note that, following hypoxia (and AIH), respiratory discharges were again entrained to ventilation rate following resumption of hyperoxic air breathing, indicating a return to the vagal-intact operational state.
Augmented Responses to Repeat Hypoxic Exposure
In addition to LTF, AIH is associated with an enhancement of peak amplitude responses in phrenic and sympathetic nerve activities during repeat brief hypoxia given at some time after the AIH protocol (75) . Similar augmentation is seen in branches of the hypoglossal nerve innervating tongue protrudor and retractor muscles (32) . The present study demonstrates an augmentation of peak RLN amplitude, predominated by an increase in postinspiratory activity that corresponds with laryngeal adductor muscle activity. The mechanism by which sensitization to repeat hypoxic insult given 60 min post-AIH arises is largely unknown. We are the first to report that, like LTF, the augmented response of phrenic and RLN to repeat hypoxia involves serotonergic mechanisms, as systemic administration of a broad-spectrum serotonergic antagonism abolishes the increase in peak amplitude of PNA and RLNA. Serotonin could be involved at several points along the hypoxic chemoreflex pathway, namely 1) sensitization of the carotid body (35, 62), 2) sensitization of second-order neurons in the caudal nucleus tractus solitarii (22, 53) , or 3) modulation of central respiratory rhythm and pattern-generating circuits by the caudal raphe, affecting the gain of respiratory motor output (59) . Alternatively, it might be argued that the same serotoninmediated sensitization of motoneurons to glutamatergic input is responsible for both LTF and augmented peak amplitude responses to hypoxia. However, our laboratory previously showed that augmented responses in PNA can occur without phrenic LTF, indicating that these mechanisms are indeed independent (75) . This is further supported by our results of a prolongation of the response to repeat hypoxia in the time domain, which cannot be explained simply by increased excitability of respiratory motoneurons. Taken together, a parsimonious explanation is that the potentiation to repeat hypoxia involves neural plasticity at an early, common stage in the hypoxic chemoreflex pathway, such as the carotid body. This is supported by work in excised rat carotid body preparation, in which activation of 5-HT 2A receptor prolonged the duration of carotid sinus nerve firing evoked by a single hypoxic challenge (40) . There is also a gradual increase in carotid sinus nerve firing with subsequent hypoxic exposures, as well as an enhanced response to repeat hypoxia (20) . Lastly, treatment with chronic intermittent hypoxia enhances peak carotid sinus nerve activity in response to hypoxia in cats (66) and rats (61, 63) . Thus AIH may sensitize carotid bodies to produce prolonged and increased amplitude of activity to hypoxia of the same magnitude. The exact site of serotonin action in enhancement of repeat hypoxia challenge remains to be elucidated.
It is noteworthy to mention that the enhanced nerve responses to repeat brief hypoxia given 60 min post-AIH differs from the "progressive augmentation" of peak nerve responses to successive stimuli during AIH and intermittent carotid sinus nerve stimulation protocols previously reported (20, 30, 31) . Progressive augmentation was not commonly observed during the AIH protocol under the experimental conditions used in this study. Interestingly, in contrast to progressive augmentation (31, 55) , the enhanced peak responses to hypoxia 60 min post-AIH does appear to rely on serotonin receptor activation, as it is not observed in the presence of methysergide. This indicates that the enhancement of hypoxic chemoreflex post-AIH is distinct from progressive augmentation and is reliant on the activation of serotonergic mechanisms, similar to the establishment of LTF.
Perspectives
In summary, the present study suggests that AIH elicits enhanced neural plasticity in all inspiratory motor outputs, including laryngeal abductor muscles, but does not further recruit expiratory muscles in the long-term increase in breathing effort. This is consistent with the current theory that LTF of respiratory motor outputs following AIH occurs via serotonergic-mediated sensitization of motoneurons to existing excitatory inputs. Based on this study, it appears that similar serotonergic-mediated mechanisms are attendant in laryngeal motoneuronal plasticity following AIH. Finally, we provide preliminary evidence that augmented amplitude and timing of responses to repeat hypoxia after the establishment of LTF also require serotonergic transmission. 
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